10/08/2024
3:30 PM | Castle Jeremy (Reporting)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
| Form 3/A | |
09/30/2024
3:30 PM | Carter Robert Ross (Reporting)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/23/2024
8:00 AM | Oncology Institute, Inc. (Filer)
Oncology Institute, Inc. (Filer)
Oncology Institute, Inc. (Filer)
Oncology Institute (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/20/2024
7:20 AM | Havencrest Healthcare Partners, L.P. (Filed by)
Oncology Institute, Inc. (Subject)
Oncology Institute, Inc. (Subject)
Oncology Institute, Inc. (Subject)
Oncology Institute (Subject)
| Form SC 13D/A | |
08/20/2024
5:15 AM | Havencrest Healthcare Partners GP, LLC (Reporting)
Havencrest Healthcare Partners, L.P. (Reporting)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
TOI HC I, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
3:17 PM | Oncology Institute, Inc. (Filer)
Oncology Institute, Inc. (Filer)
Oncology Institute, Inc. (Filer)
Oncology Institute (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/21/2024
3:30 PM | Oncology Institute, Inc. (Filer)
Oncology Institute, Inc. (Filer)
Oncology Institute, Inc. (Filer)
Oncology Institute (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
06/20/2024
3:17 PM | Hively Brad (Reporting)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
4:07 PM | Oncology Institute, Inc. (Filer)
Oncology Institute, Inc. (Filer)
Oncology Institute, Inc. (Filer)
Oncology Institute (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/23/2024
6:22 PM | Hively Brad (Reporting)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
5:33 PM | Castle Jeremy (Reporting)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
5:33 PM | Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
Podnos Yale (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
5:33 PM | Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
Shah Mihir (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
5:33 PM | Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
Virnich Daniel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2024
3:20 PM | Oncology Institute, Inc. (Filer)
Oncology Institute, Inc. (Filer)
Oncology Institute, Inc. (Filer)
Oncology Institute (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/14/2024
3:03 PM | Oncology Institute, Inc. (Filer)
Oncology Institute, Inc. (Filer)
Oncology Institute, Inc. (Filer)
Oncology Institute (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2024
3:55 PM | Oncology Institute, Inc. (Filer)
Oncology Institute, Inc. (Filer)
Oncology Institute, Inc. (Filer)
Oncology Institute (Filer)
| Form DEF 14A | |
05/02/2024
3:57 PM | Oncology Institute, Inc. (Filer)
Oncology Institute, Inc. (Filer)
Oncology Institute, Inc. (Filer)
Oncology Institute (Filer)
| Form DEFA14A | |
04/26/2024
2:11 PM | Oncology Institute, Inc. (Filer)
Oncology Institute, Inc. (Filer)
Oncology Institute, Inc. (Filer)
Oncology Institute (Filer)
| Form ARS | |
04/22/2024
3:30 PM | Oncology Institute, Inc. (Filer)
Oncology Institute, Inc. (Filer)
Oncology Institute, Inc. (Filer)
Oncology Institute (Filer)
| Form 10-K/A | |
04/22/2024
3:31 PM | Oncology Institute, Inc. (Filer)
Oncology Institute, Inc. (Filer)
Oncology Institute, Inc. (Filer)
Oncology Institute (Filer)
| Form PRE 14A | |
03/28/2024
5:47 AM | Oncology Institute, Inc. (Filer)
Oncology Institute, Inc. (Filer)
Oncology Institute, Inc. (Filer)
Oncology Institute (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
01/30/2024
6:07 PM | Havencrest Healthcare Partners GP, LLC (Reporting)
Havencrest Healthcare Partners, L.P. (Reporting)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
TOI HC I, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/26/2024
6:19 PM | Havencrest Healthcare Partners GP, LLC (Reporting)
Havencrest Healthcare Partners, L.P. (Reporting)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
TOI HC I, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2024
7:02 PM | Havencrest Healthcare Partners GP, LLC (Reporting)
Havencrest Healthcare Partners, L.P. (Reporting)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
TOI HC I, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
3:00 PM | Havencrest Healthcare Partners GP, LLC (Reporting)
Oncology Institute, Inc. (Subject)
Oncology Institute, Inc. (Subject)
Oncology Institute, Inc. (Subject)
Oncology Institute (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/02/2024
4:01 PM | Havencrest Healthcare Partners GP, LLC (Reporting)
Havencrest Healthcare Partners, L.P. (Reporting)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
TOI HC I, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2024
4:06 PM | Havencrest Healthcare Partners, L.P. (Filed by)
Oncology Institute, Inc. (Subject)
Oncology Institute, Inc. (Subject)
Oncology Institute, Inc. (Subject)
Oncology Institute (Subject)
| Form SC 13D/A | |
12/28/2023
4:58 PM | BARASCH RICHARD A (Reporting)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
4:46 PM | Hively Brad (Reporting)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
4:38 PM | Johnson Karen Marie (Reporting)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
4:27 PM | Kaushal Mohit (Reporting)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
3:58 PM | O'Meara Maeve (Reporting)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
4:06 PM | McGeorge Anne (Reporting)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
4:16 PM | Ling Gabriel (Reporting)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
3:09 PM | Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
Pacala Mark L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
2:26 PM | Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
Shah Mihir (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2023
6:42 PM | Castle Jeremy (Reporting)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
8:01 PM | Hively Brad (Reporting)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
7:47 PM | Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
Virnich Daniel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
7:37 PM | Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
Podnos Yale (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
625,000% Gain (Ad) Imagine swapping your daily coffee expense for a future free of financial worries.
It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market.
Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz. >> Dive into the Workshop Here |
11/21/2023
6:27 PM | Hively Brad (Reporting)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/17/2023
4:27 PM | Hively Brad (Reporting)
Oncology Institute, Inc. (Subject)
Oncology Institute, Inc. (Subject)
Oncology Institute, Inc. (Subject)
Oncology Institute (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/16/2023
3:40 PM | Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
Podnos Yale (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2023
5:49 PM | Hively Brad (Reporting)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2023
4:17 PM | Hively Brad (Reporting)
Oncology Institute, Inc. (Subject)
Oncology Institute, Inc. (Subject)
Oncology Institute, Inc. (Subject)
Oncology Institute (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
